Philip Grossen


Office room number 2014
Pharmaceutical Technology
Klingelbergstrasse 50
CH-4056 Basel

Office phone
+41 (0)61 207 15 09

Philip Grossen graduated at the University of Basel and received his license as pharmacist in 2013. He conducted his master thesis about the potential of rodent
Parvoviruses in Glioma therapy ("2nd and 3rd generation of oncolytical Parvovirus therapy of cancer") at the German Cancer Research Institute (DKFZ) in Heidelberg. This work was awarded with the "Amedis Förderpreis 2012". In November 2013 he joined the Pharmaceutical Technology group as a PhD student. His research is focused on the implementation of drug delivery strategies to the brain.

Latest Publications

Kiene, Klara; Schenk, Susanne H.; Porta, Fabiola; Ernst, Alexandra; Witzigmann, DominikGrossen, PhilipHuwyler, Jörg: PDMS-b-PMOXA polymersomes for hepatocyte targeting and assessment of toxicity, in: European Journal of Pharmaceutics and Biopharmaceutics 119, 2017, S. 322-332. edoc
Grossen, PhilipWitzigmann, DominikSieber, SandroHuwyler, Jörg: PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application, in: Journal of Controlled Release 260, 2017, S. 46-60. edoc
Sieber, SandroGrossen, PhilipDetampel, Pascal; Siegfried, Salome; Witigmann, Dominik; Huwyler, Jörg: Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo, in: Journal of Controlled Release 264, 2017, S. 180-191. edoc

> All Publications